Stock Scorecard
Stock Summary for Lipocine Inc (LPCN) - $7.29 as of 3/17/2026 2:34:35 AM EST
Total Score
13 out of 30
Safety Score
20 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for LPCN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LPCN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LPCN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for LPCN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for LPCN (20 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 2 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for LPCN
Financial Details for LPCN
Company Overview |
|
|---|---|
| Ticker | LPCN |
| Company Name | Lipocine Inc |
| Country | USA |
| Description | Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 7.29 |
| Price 4 Years Ago | 6.76 |
| Last Day Price Updated | 3/17/2026 2:34:35 AM EST |
| Last Day Volume | 47,302 |
| Average Daily Volume | 127,061 |
| 52-Week High | 12.37 |
| 52-Week Low | 2.52 |
| Last Price to 52 Week Low | 189.29% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 24.56 |
| Sector PE | 40.66 |
| 5-Year Average PE | 48.99 |
| Free Cash Flow Ratio | 7.76 |
| Industry Free Cash Flow Ratio | 10.30 |
| Sector Free Cash Flow Ratio | 22.88 |
| Current Ratio Most Recent Quarter | 6.68 |
| Total Cash Per Share | 0.94 |
| Book Value Per Share Most Recent Quarter | 2.35 |
| Price to Book Ratio | 2.88 |
| Industry Price to Book Ratio | 54.44 |
| Sector Price to Book Ratio | 36.53 |
| Price to Sales Ratio Twelve Trailing Months | 20.62 |
| Industry Price to Sales Ratio Twelve Trailing Months | 32.06 |
| Sector Price to Sales Ratio Twelve Trailing Months | 12.34 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 5,551,900 |
| Market Capitalization | 40,473,351 |
| Institutional Ownership | 22.37% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 100.05% |
| Reported EPS 12 Trailing Months | -1.02 |
| Reported EPS Past Year | -1.35 |
| Reported EPS Prior Year | 0.01 |
| Net Income Twelve Trailing Months | -5,475,238 |
| Net Income Past Year | 8,352 |
| Net Income Prior Year | -16,352,082 |
| Quarterly Revenue Growth YOY | -67.20% |
| 5-Year Revenue Growth | 132.45% |
| Operating Margin Twelve Trailing Months | -219.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 5,205,842 |
| Total Cash Past Year | 5,205,842 |
| Total Cash Prior Year | 6,205,926 |
| Net Cash Position Most Recent Quarter | 4,372,842 |
| Net Cash Position Past Year | 3,538,842 |
| Long Term Debt Past Year | 1,667,000 |
| Long Term Debt Prior Year | 1,667,000 |
| Total Debt Most Recent Quarter | 833,000 |
| Equity to Debt Ratio Past Year | 0.90 |
| Equity to Debt Ratio Most Recent Quarter | 0.95 |
| Total Stockholder Equity Past Year | 14,477,416 |
| Total Stockholder Equity Prior Year | 20,997,565 |
| Total Stockholder Equity Most Recent Quarter | 14,477,416 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -5,149,313 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.93 |
| Free Cash Flow Past Year | -1,311,319 |
| Free Cash Flow Prior Year | -11,879,158 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.01 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 3/17/2026 2:34:36 AM EST |